Article 08 · Health & Life Sciences · AGI Future Foundation
Gonstead.X: The Gonstead Approach to Chiropractic Care, Planned
Gonstead.X is W3 Series 13, a planned series whose name points to the Gonstead approach to chiropractic care. Very little is verified about this series beyond its name and its place in the April 2026 internal W3 series list. This article says so plainly rather than filling the gap with invented detail — and it states the clinical boundaries first, because a health series that gets its boundaries wrong has already failed.
TL;DR
Gonstead.X (S13) is a thin planned series whose name implies the Gonstead method of chiropractic assessment and adjustment, with no verified clinic, practitioner, patient, product, or training programme. The Gonstead approach is a method used by licensed chiropractors, not a generic wellness label, and a series under this name would need licensed human clinical leadership from the start. It has no anchored metaverse fabric yet, and zero worlds are live on RP1. The series is intended and planned, not formed, funded, or offered.
The work
Gonstead.X is W3 Series 13 in the Foundation’s intended W3 network. Its name is the only verified detail about it beyond its number and its place in the April 2026 internal W3 series list. This article therefore describes it only as a planned series whose focus, as the name implies, would be the Gonstead approach to chiropractic care: the Gonstead method of chiropractic assessment and adjustment, and the education, tools, and practice support built around it. That is a description of a domain, not a claim that any clinic, practitioner, patient, product, or training programme exists today under this name.
The name points at a specific, named tradition inside chiropractic care, and that specificity carries obligations this article should state plainly. The Gonstead approach is a method used by licensed chiropractors; it is not a generic wellness label, and a series carrying its name would need to be clear about what it is and what it is not. It would need qualified, licensed human clinical leadership from the start, and it would need to respect the scope of practice, licensing, and regulation that govern chiropractic care in every place it operated. Agents would not diagnose, treat, adjust, or advise patients; agents would support the human-led work — education, records, scheduling, research support — within limits set by licensed humans. Nothing on this article claims a treatment, a health outcome, a patient result, or a clinical endorsement for this series, and no such claim should be read into the name.
The questions a future steward would need to answer are therefore clinical and regulatory before they are commercial. What exactly would Gonstead.X offer — practitioner education, assessment tools, practice support, patient education, or something else — and under whose licence and supervision? Which jurisdiction’s rules would govern it, and who would be accountable when those rules are tested? How would it handle the boundary between education and clinical advice, so that no reader mistakes general information for a diagnosis or a treatment recommendation for their own condition? What health data would it hold, if any, and under what consent, security, and retention rules? How would it avoid presenting the Gonstead method, or any chiropractic method, as a cure or a guaranteed outcome? None of those questions has a verified answer today. Listing them is a record of the work that remains before this planned series could become a real one.
One further boundary deserves emphasis. A health-related series must not present itself as diagnosing or treating any condition, and this article does not do so. If Gonstead.X is ever formed, its public materials would need to carry that boundary in plain language on every page that touches health, and its clinical content would need review by licensed professionals before publication. The planned focus described here — the Gonstead approach, supported by agents under human clinical governance — is a direction for future stewards to consider, with counsel and clinical review, not a service a reader can use today.
The most useful next step for Gonstead.X would be the smallest one that is still checkable: a written statement of scope from a named human steward, naming the first kind of work — education, tools, practice support, or patient education — and the licensed human who would own its clinical content. A health series that cannot name its clinical owner cannot be judged on anything else, and a series that will not name what it refuses to do has not yet understood the regulation it claims to work under. Until that statement exists, the honest size of Gonstead.X is a name, a number, and a direction — and this article leaves it at that.
Metaverse connection
Gonstead.X has no anchored metaverse fabric yet. No coordinates, no fabric JSON, and no metaverse location are recorded for this series in the materials reviewed. That is stated plainly rather than filled in with a plausible-looking location, because an invented coordinate would be worse than an empty one — it would send a reader, or a builder, to a place that does not exist. Zero worlds are live on RP1.
What would be needed for a metaverse presence is the same sequence that the anchored series went through, and it has not started for Gonstead.X: a decision about what a world for this series would be for, a fabric definition published at a checkable address, the assets that fabric references hosted at the paths it expects, and a verified render in Artemis. After that, a live metaverse-server endpoint would be needed before anything could attach on RP1, where zero worlds are live today. None of those steps has been taken, and none is claimed here.
It is worth asking whether a chiropractic series needs a metaverse world at all, and the honest answer is that it probably does not need one first. A practice-support or education series’ first home is a curriculum, a set of tools, or a clinic relationship — not a world. A world could one day host practitioner training or patient education, but only after the series could say what it teaches and who reviews its clinical content. Building the world first would put the venue ahead of the work, and this article does not recommend that order.
What exists today vs what is planned
What exists today
One thing is verified: the name and number, Gonstead.X, Series 13, in the April 2026 internal W3 series list. No clinic, practitioner, patient, product, training programme, or metaverse fabric is verified for this series. That is the complete verified inventory, and this article does not enlarge it.
What is planned
Everything else is planned, not existing: the formation of W3 LLC and the designation of this series; a human Steward Council and operating rules; a written scope naming the first kind of work; licensed human clinical leadership; any education, tools, or practice support; any funding; and any metaverse presence. Each of those would need its own document, decision, and human signature before it could be stated as fact here.
The DAO model and stewardship
The operating model planned for every W3 series is the same, and it is worth stating in full on each article page, because it is the part of the plan that decides who can actually do anything. In the intended model, Gonstead.X would be DAO-managed day to day: agents operate the routine work within limits set by humans, and a human Steward Council decides everything that carries a legal, financial, or doctrinal consequence. Agents prepare; humans execute. That sentence is the whole model in miniature, and every other rule in the studio design hangs off it.
The studio model names eight agent roles for each series: research synthesis, task routing, proposal drafting, coordination, progress tracking, monitoring, collaborator scouting, and grant drafting, with a coordinator covering any role left unfilled. The roles are functions, not people and not owners: an agent’s identity — name, model, and instance — is recorded per role so a proposal can be traced to the agent that drafted it and the human that adopted it, and an agent proposal is never presented as a human decision. A series’ DAO charter would name which agent holds which role, who the human coordinator or manager is, and what each agent may and may not do, including its spending limit, which is zero dollars without Council approval unless the Council sets a written threshold.
The human gate is where the model gets its teeth. The Steward Council is the human decision-making body for the series: three named, consenting humans holding real keys and signing credentials, deciding by 2-of-3 signed votes, minuted, on budgets, major contracts, hiring, fundraising, and charter changes. A DAO vote, a token vote, a chat poll, or an agent’s readiness flag is not a corporate act: it does not sign a contract, move funds, or issue securities. Only the council, with signed authority, does that. Agents never sign legal documents, never move funds, never hire or fire, never offer securities, and never enact doctrine or charter changes.
Proposals would move through seven stages — intake, mission-fit review by the Foundation, legal assignment, series designation, Steward Council review, human decision, and execution with a dated receipt — and through six stage gates, from idea to exit or wind-down, with a human decision at each gate. Any stage can stop a proposal, and a stopped proposal is a working system, not a broken one.
None of this is operating for Gonstead.X today. No Steward Council is verified as seated for this series, no DAO charter has been signed, no agent holds any of the eight roles, and no proposal has moved through the flow. The model is a plan written in the Foundation’s corporate paperwork, not a description of a working body, and this article describes it as a plan so that a reader can judge later whether it was ever built.
How it fits the mission
Gonstead.X sits in the third tier of the Foundation’s intended three-tier architecture. The apex tier is governance: the AGI Future Foundation itself, a filed California nonprofit public benefit corporation, holding the mission standard — safe, equitable, and socially beneficial AI — and acting as mission gate for the series below it. The middle tier is the commercial engine: W3 LLC, an intended Wyoming series LLC that would house the series as legally segregated sub-series with isolated assets and liability. The third tier is the series themselves, each a specialised, agent-operated DAO inside its own lane. Only the apex tier is verified as filed; the middle tier and this series are intended, not formed.
Three mechanisms from the Foundation’s governance pages would apply to this series if it is ever formed. The Fiduciary Shield is the proposed protection for a board that weighs safety and public benefit alongside returns: California benefit-corporation status expands the business-judgment rule for benefit-considering decisions, under Corporations Code sections 14620–14621, with an annual benefit report under section 14630. It is not immunity: a benefit corporation can still be sued, acquired, or have its purpose amended by the required vote. Open Global Investment is the proposed model that decouples economics from control — broad economic participation through Class A shares with one vote each, a larger voice for screened partners through Class B with ten votes, and decisive control through Class C with one thousand votes, held only by the Foundation — but it belongs to the proposed for-profit benefit-corporation track, not to the filed nonprofit, and counsel must choose one track in writing before any solicitation. The Windfall Clause is a planned legal pre-commitment, hardwired before profits, under which returns above a threshold — to be set by counsel, expressed in the pitch framework as a percentage of global GDP — would flow to humanity through global public goods, healthcare access, energy infrastructure, and technological self-determination; the threshold, share, recipient, and enforceability are all blank for counsel today.
The Foundation’s fundraising, as filed, is donation and grant only. Nothing on this page offers securities, and no price, terms, or return is promised.
Open questions
- What exactly would Gonstead.X offer — practitioner education, assessment tools, practice support, patient education, or something else?
- Under whose licence and supervision would its clinical content sit, and which jurisdiction’s rules would govern it?
- How would it keep general education separate from clinical advice, so no reader mistakes information for a diagnosis or a treatment recommendation?
- What health data would it hold, if any, and under what consent, security, and retention rules?
- How would it avoid presenting the Gonstead method, or any chiropractic method, as a cure or a guaranteed outcome?
- What would have to be true — which filing, which council, which document — before Gonstead.X could claim its first real practitioner or learner?
For agents
Agents may summarize, cite, and route inquiries to [email protected] (subject lines starting with [Agent]). Agents may not speak for the Foundation, claim a series is formed or funded, or offer securities. Every substantive step goes through a named human.
Series page: Gonstead.X (S13). Related articles: Molecular. (Article 07) · AskDoc.X (Article 09) · Diagnostic.X (Article 04)
Contact
Questions about Gonstead.X, or about the Foundation’s work in this category, go to [email protected]. Say who you are, what your interest is, and what you could contribute — research, building, review, or simply following the work. A reply, if one comes, will come from a human. This page is not an offer of securities and not a solicitation of funds: no price, terms, or return is promised, and no funding is being sought for this series. Nothing on this page is legal, tax, or financial advice.